Cardiovascular diseases (CDs) are the major causes of death in first world countries. Specifically, myocardial infarction (MI), commonly known as heart attack, causes irreparable loss of cardiomyocytes and impairment of the heart muscle. Over time, this leads to over stressed non-impaired regions, weakening the myocardium through fatigue. In this context, cardiac tissue engineering (CTE) aims to develop functional engineered cardiac tissues (ECTs) to be used as functional in vitro models for cardiac research or drug testing, with the ultimate but still challenging goal of repairing the damaged heart tissue. Multiple studies have shown that physical stimuli are crucial for the development of functional engineered tissues in vitro.